Summary:
Patient-reported outcomes (PROs) are increasingly recognized by regulators, clinicians, and patients as valuable tools to collect patient-centered data. This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs about how to incorporate PROs into clinical trials in ways that improve probabilities of success while avoiding common mistakes. Specifically, the panelists address:
- How PROs provide evidence on the effect of interventions on patient symptoms and quality of life, but, by the nature of being subjective, they are prone to bias
- The growth of electronic health technologies provides unprecedented opportunities to systematically collect PROs
- Disadvantages of electronic methods include technical difficulties, cost, longer start-up time, and “digital divide” between patients
To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
Moderators
Barry Ticho, MD, PhD
CMO
Stoke Therapeutics, Inc
Panelists
Wessam Sonbol
CEO
Delve Health
Nataliya Agafonova, MD
CMO
Longeveron Inc.
Jason Sager, MD
CMO
Accent Therapeutics, Inc.
Dawie Wessels
CMO
Signant Health
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.